Buprenorphine + Naloxone Sublingual Films/tablets Generics - Manufacturers & Suppliers
Suboxone(US)
| Product/Composition:- | Buprenorphine + Naloxone Sublingual Films/Tablets |
|---|---|
| Strength:- | 2 mg buprenorphine / 0.5 mg naloxone, 8 mg / 2 mg |
| Form:- | Sublingual Films/Tablets |
| Reference Brands:- | Suboxone(US) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Buprenorphine + Naloxone sublingual films/tablets activate mu-opioid receptors, relieving pain and preventing withdrawal. Naloxone blocks opioid effects if injected, reducing misuse. Benefits include effective pain relief, lower overdose risk when used properly, and convenience of sublingual administration, promoting adherence and safety in opioid dependence and pain management.
Buprenorphine + Naloxone sublingual films and tablets are approved in the EU and US primarily for opioid dependence treatment, with some off-label use for pain. In the US, brands like Suboxone are regulated by the FDA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the EU, approval by EMA involves comprehensive dossiers, clinical data, and pharmacovigilance plans. Due to abuse potential, strict prescribing controls and monitoring are enforced. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for buprenorphine + naloxone formulations, ensuring adherence to European and US standards for safe, effective opioid dependence management and pain therapy.